Larotaxel: broadening the road with new taxanes (Q37551909)

21 August 2017

1 reference

title

Larotaxel: broadening the road with new taxanes (English)

1 reference

21 August 2017

3

Evandro de Azambuja

0 references

author name string

Otto Metzger-Filho

series ordinal

1

1 reference

21 August 2017

Camilo Moulin

series ordinal

2

1 reference

21 August 2017

Awada Ahmad

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Investigational Drugs

21 August 2017

published in

1 reference

21 August 2017

volume

18

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

1183-1189

1 reference

Trastuzumab--mechanism of action and use in clinical practice

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Novel formulations of taxanes: a review. Old wine in a new bottle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Microtubule active agents: beyond the taxane frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Markers predicting clinical benefit in breast cancer from microtubule-targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Role of formulation vehicles in taxane pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Microtubule dynamics: mechanism, regulation, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

High-resolution model of the microtubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Physiochemical aspects of tubulin-interacting antimitotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

A population pharmacokinetic model for docetaxel (Taxotere): model building and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Potential for improvement of docetaxel-based chemotherapy: a pharmacological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Mechanisms of disease: the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Chemotherapy delivery issues in central nervous system malignancy: a reality check.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Brain metastases: the HER2 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903119167

10.1517/13543780903119167

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference